Shares Outstanding (Quarterly) Chart

Historical Shares Outstanding (Quarterly) Data

View and export this data back to 2017. Start Trial.
Date Value
June 30, 2026 0.608M
March 31, 2026 0.6059M
December 31, 2025 0.5459M
September 30, 2025 0.5279M
June 30, 2025 0.4394M
March 31, 2025 0.4373M
December 31, 2024 0.3637M
September 30, 2024 0.3616M
June 30, 2024 0.3594M
March 31, 2024 0.3571M
December 31, 2023 0.3535M
September 30, 2023 0.3493M
June 30, 2023 0.344M
March 31, 2023 0.3109M
December 31, 2022 0.3108M
September 30, 2022 0.3107M
June 30, 2022 0.3106M
March 31, 2022 0.3103M
Date Value
December 31, 2021 0.3101M
September 30, 2021 0.3094M
June 30, 2021 0.3091M
March 31, 2021 0.2438M
December 31, 2020 0.2432M
September 30, 2020 0.2426M
June 30, 2020 0.199M
March 31, 2020 0.1982M
December 31, 2019 0.1971M
September 30, 2019 0.1962M
June 30, 2019 0.1958M
March 31, 2019 0.1957M
December 31, 2018 0.1957M
September 30, 2018 0.1957M
June 30, 2018 0.1957M
March 31, 2018 0.1957M
December 31, 2017 0.1957M

Shares Outstanding Definition

The volume of stock shares issued by the company and in the hands of the public. This number entails how much is being traded in the open market. A decreasing shares outstanding over time may be the result of company buybacks. Companies frequently make stock buybacks and retire those buybacks as treasury stock.

Read full definition.

Shares Outstanding (Quarterly) Range, Past 5 Years

View Shares Outstanding (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Shares Outstanding (Quarterly) Benchmarks

View Shares Outstanding (Quarterly) Benchmarks
Start Trial
Q32 Bio, Inc. 23.74M
IRulya Therapeutics, Inc. 1.017M
Climb Bio, Inc. 57.44M
PepGen Inc. 69.26M
Bridgebio Oncology Therapeutics, Inc. 80.12M